Additional information
Off white powder
2226541-13-3
ACI-047016
189.6-191.8°C
C35H41N7O4
623.74
Ambient
2-8°C
Antiviral
Pharmaceutical Impurity Standards
Methyl [(2S)-1-(2S)-2-[5-(4'-2-[(2S)-1-acetylpyrrolidin-2-yl]-1H-imidazol-5-ylbiphenyl -4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl-3-methyl-1-oxobutan-2-yl]carbamate
Methyl [(2S)-1-(2S)-2-[5-(4'-2-[(2S)-1-acetylpyrrolidin-2-yl]-1H-imidazol-5-ylbiphenyl -4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl-3-methyl-1-oxobutan-2-yl]carbamate
N-[(1S)-1-[[(2S)-2-[5-[4'-[2-[(2S)-1-Acetyl-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester carbamic acid





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)